2389988-36-5
Chemical Structure
TLR7 agonist 11
- CAS No.: 2389988-36-5
- Formula:C14H17N5O8
- Molecular Weight:383.31
IUPAC Name: (E)-4-(2-amino-9-((2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-6,8-dioxo-1,6,8,9-tetrahydro-7H-purin-7-yl)but-2-enoic acid
InChIKey: DBUALASPQQKXPE-HCDIHNFBSA-N
SMILES: OC[C@@H]1[C@H](O)[C@@H](O)[C@H](N(C(N2C/C=C/C(O)=O)=O)C3=C2C(NC(N)=N3)=O)O1
Biological Activity: TLR7 agonist 11 is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
TLR7 agonist 11 | TLR7 agonist 11 is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
